Website profile

Tradingview

Where the world charts, chats and trades markets. We're a supercharged super-charting platform and social network for traders and investors. Free to sign up.

  • 234,841articles · 365d
  • 58+ min agolatest article
  • Sep 14, 2025earliest in window
  • 93%with images · 64 videos
  • 137avg words
articles per day
Categories
  • Economy, Business & Finance 224,042
  • Finance & Business 218,075
  • News 122,532
  • Finance 64,092
  • Business & Industrial 28,023
  • Industrial 5,224
  • Health & Wellness 4,213
  • Computers & Electronics 2,619

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > urn:summary_document_slides:quartr.com:4036243:0-peb-draft-medicare-coverage-for-cxbladder-tests-marks-a-pivotal-step-toward-renewed-growth

PEB: Draft Medicare coverage for Cxbladder tests marks a pivotal step toward renewed growth

3+ week, 3+ day ago   (83+ words) TradingView PEB: Draft Medicare coverage for Cxbladder tests marks a pivotal step toward renewed growth The meeting highlighted a challenging year marked by Medicare non-coverage, resulting in lower revenue and higher losses, but also celebrated the draft Medicare coverage for…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4010758:0-cph-canadian-epuris-growth-offset-u-s-medicaid-headwinds-sustaining-high-profitability

CPH: Canadian Epuris growth offset U.S. Medicaid headwinds, sustaining high profitability

1+ mon, 23+ hour ago   (65+ words) TradingView CPH: Canadian Epuris growth offset U.S. Medicaid headwinds, sustaining high profitability Q2 2026 saw strong profitability and cash flow, with Canadian Epuris growth offsetting U.S. Natroba revenue pressure from Medicaid changes. Gross margin remained high at 80%, and new retail and DTC strategies are…...

TradingView
tradingview.com > news > zacks:91317bf8a094b:0-alhc-trends-to-watch-as-ai-automation-reshapes-medicare-economics

ALHC Trends to Watch as AI Automation Reshapes Medicare Economics

2+ mon, 4+ day ago   (736+ words) Alignment Healthcare ALHC offers a timely view of how Medicare Advantage operators are trying to improve economics through technology, quality plan design and selective growth. The company still faces medical-cost, risk-adjustment and provider-alignment pressures. Yet its progress shows how automation…...

TradingView
tradingview.com > news > zacks:0bdd5b507094b:0-unh-s-1-5b-ai-push-can-it-deliver-more-than-cost-savings

UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?

2+ mon, 4+ day ago   (175+ words) How Are Competitors Faring? Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. HUM and Centene Corporation CNC. Humana is expanding AI across care management, prior authorization and member engagement to improve efficiency and health…...

TradingView
tradingview.com > news > reuters.com,2026:newsml_L1N43A0QH:0-obamacare-insurers-ask-for-second-highest-premiums-increase-in-nearly-a-decade

Obamacare insurers ask for second-highest premiums increase in nearly a decade

2+ mon, 4+ day ago   (29+ words) TradingView Obamacare insurers ask for second-highest premiums increase in nearly a decade More news from Reuters...

TradingView
tradingview.com > news > modular_finance:b277ee12242fb:0-humana-finland-expands-its-pipeline-for-organic-growth

Humana Finland expands its pipeline for organic growth

2+ mon, 2+ week ago   (159+ words) TradingView Humana Finland expands its pipeline for organic growth Over the past year, Humana has strengthened its focus on organic growth, including a strengthened sales organization in Finland. The expansion is primarily driven by demand within disability, and a pipeline…...

TradingView
tradingview.com > news > zacks:3cf6943c2094b:0-can-humana-s-margin-recovery-drive-long-term-earnings-growth

Can Humana's Margin Recovery Drive Long-Term Earnings Growth?

2+ mon, 2+ week ago   (375+ words) Humana Inc. HUM has spent the past two years dealing with higher medical costs as more seniors returned for treatments that were delayed during the pandemic. The pressure weighed heavily on Medicare Advantage margins and profitability. The company is now…...

TradingView
tradingview.com > news > tradingview:d1f9396238471:0-clover-reports-cms-recalculation-boosts-two-medicare-advantage-contracts-to-4-5-stars-for-2027

Clover reports CMS recalculation boosts two Medicare Advantage contracts to 4.5 Stars for 2027

2+ mon, 3+ week ago   (100+ words) TradingView Clover reports CMS recalculation boosts two Medicare Advantage contracts to 4.5 Stars for 2027 Clover announced CMS recalculated Star Ratings that raise two Medicare Advantage contracts to 4.5 Stars for payment year 2027. - CMS recalculated Clover's PPO contract H5141 from 3.5 to 4.5 Stars, affecting 2027 Quality…...

TradingView
tradingview.com > news > tradingview:0a98eee62e33f:0-humana-inc-stock-12-month-price-target-raised-to-283-54-implies-13-downside

Humana Inc. Stock 12‑Month Price Target Raised to $283.54, Implies 13% Downside

3+ mon, 1+ week ago   (116+ words) TradingView Humana Inc. Stock 12‑Month Price Target Raised to $283.54, Implies 13% Downside - According to estimates from 24 analysts, Humana Inc. stock's average price target has risen from $279.17 to $283.54, with forecasts ranging from $195 to $441 per share - Based on the Jun. 3 closing price, the…...

TradingView
tradingview.com > news > tradingview:f9bf8f835fc8d:0-selectis-health-inc-1q-2026-revenue-7-29m-eps-1-9-10-q-summary

SELECTIS HEALTH, INC. 1Q 2026: Revenue $7.29M, EPS $1.9— 10-Q Summary

3+ mon, 3+ week ago   (197+ words) TradingView SELECTIS HEALTH, INC. 1Q 2026: Revenue $7.29M, EPS $1.9— 10-Q Summary SELECTIS HEALTH, INC. reported first-quarter 2026 results with revenue of $7.29M and net income of $6.52M attributable to common stockholders; diluted earnings per share were $1.9, driven largely by gains on recent facility sales despite a…...